www.medicortex.fi Open in urlscan Pro
217.30.188.173  Public Scan

Submitted URL: http://www.medicortex.fi/
Effective URL: https://www.medicortex.fi/
Submission: On October 20 via api from US — Scanned from FI

Form analysis 3 forms found in the DOM

GET /eng/

<form method="get" action="/eng/" class="searchform" id="searchform1">
  <p class="spamfilter"><input type="text" name="e" value=""><input type="text" name="c" value="e"></p>
  <label for="searchterm1" class="searchterm-label hide_label">Find on website</label> <input type="submit" class="submit jssubmit" value="Search" id="js_submit_1" style="display: none;"><a class="submitlike" id="js_link_1" style="">Search</a><input
    type="text" name="keyword" onblur="if(this.value==''){this.value='Enter keyword';}" onfocus="if(this.value=='Enter keyword'){this.value='';}" value="Enter keyword" id="searchterm1" class="searchterm">
</form>

GET /eng/

<form method="get" action="/eng/" class="searchform" id="searchform2">
  <p class="spamfilter"><input type="text" name="e" value=""><input type="text" name="c" value="e"></p>
  <label for="searchterm2" class="searchterm-label hide_label">Find on website</label> <input type="submit" class="submit jssubmit" value="Search" id="js_submit_2" style="display: none;"><a class="submitlike" id="js_link_2" style="">Search</a><input
    type="text" name="keyword" onblur="if(this.value==''){this.value='Enter keyword';}" onfocus="if(this.value=='Enter keyword'){this.value='';}" value="Enter keyword" id="searchterm2" class="searchterm">
</form>

GET /eng/

<form method="get" action="/eng/" class="searchform" id="searchform3">
  <p class="spamfilter"><input type="text" name="e" value=""><input type="text" name="c" value="e"></p>
  <label for="searchterm3" class="searchterm-label hide_label">Find on website</label> <input type="submit" class="submit jssubmit" value="Search" id="js_submit_3" style="display: none;"><a class="submitlike" id="js_link_3" style="">Search</a><input
    type="text" name="keyword" onblur="if(this.value==''){this.value='Enter keyword';}" onfocus="if(this.value=='Enter keyword'){this.value='';}" value="Enter keyword" id="searchterm3" class="searchterm">
</form>

Text Content

   
 * Contact us
 * Suomeksi



Find on website Search
 * HOME
 * INVESTORS
   * Investors
   * Why invest?
   * Reports and presentations
   * Corporate Governance
     * Articles of Association
     * General Meetings
     * Board of Directors
     * Management
     * Auditor
   * Releases
   * Investor relations
 * TECHNOLOGY
   * Technology
   * Traumatic brain injury
   * Biomarker R&D program
     * Proof of concept
     * Second clinical trial
     * Third clinical trial
     * Assay development plan
     * Drug development program
   * IP rights
 * COMPANY PROFILE
   * Company Profile
   * Business Strategy
   * Board of Directors
   * Management
   * Team
   * Scientific and Clinical Advisory Board
   * Partners
 * NEWS & EVENTS
   * News & events
   * Company releases
   * Yhtiötiedotteet
   * Press Releases
   * Lehdistötiedotteet
   * Articles
   * Videos
 * CONTACT US



Find on website Search

 * Traumatic Brain Injury (TBI) diagnosis and treatment are unmet needs in the
   medical field.
   
   

 * No diagnostic tools for assessing the extent and severity of a TBI exist.
   
   

 * Therapy development is at the core of Medicortex R&D plan.
   
   

 * In the future, TBI and concussion patients will have a valid diagnostic tool
   and treatment.
   
   

 1. 1
 2. 2
 3. 3
 4. 4


ABOUT US

Medicortex Finland is dedicated to improving the diagnostics, treatment and
prevention of acute neurodegenerative conditions and is currently focused on
developing a diagnostic kit for the detection of Traumatic Brain Injury (TBI).

Read More

R&D PROGRAMS



JOIN OUR MAILING LIST



INVESTORS / SIJOITTAJAT


NEWS & EVENTS

1
Jul 2022


MEDICORTEX AVAA OSAKEANTIKAMPANJAN (MERKINTÄAIKAA JATKETTU 19.7. ASTI)

1
Jul 2022


MEDICORTEX ANNOUNCES A FUNDRAISING CAMPAIGN (EXTENDED TO 19 JULY)

28
Jun 2022


MEDICORTEX ON JULKAISSUT YHTIÖTIEDOTTEEN: LISTAUTUMISANTI JA LISTAUTUMINEN
PERUTAAN

28
Jun 2022


MEDICORTEX HAS PUBLISHED A COMPANY RELEASE: IPO AND LISTING CANCELLED

More news

MEDICORTEX FINLAND OY



Pharma City
Itäinen Pitkäkatu 4 B, 4th floor
FI-20520 Turku, Finland
Tel. +358 (0)400 488817
adrian.harel@medicortex.fi

   
 * Contact us
 * Suomeksi



Find on website Search
   
 * INVESTORS
 * Why invest?
 * Reports and presentations
 * Corporate Governance
 * Releases
 * Investor relations

   
 * TECHNOLOGY
 * Traumatic brain injury
 * Biomarker R&D program
 * IP rights

   
 * COMPANY PROFILE
 * Business Strategy
 * Board of Directors
 * Management
 * Team
 * Scientific and Clinical Advisory Board
 * Partners

   
 * NEWS & EVENTS
 * Company releases
 * Yhtiötiedotteet
 * Press Releases
 * Lehdistötiedotteet
 * Articles
 * Videos

   
 * CONTACT US

VERKKOVARAANI